CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $2.39B, above the global median of $1.18B
- FinancialsAltman Z-Score 10.65: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.17%Below 5Y avg (1.25%)
Annual Rate
CNY 1.00Paid annual
Payout Ratio
54.7%Sustainable
Payback Period
86.8 yr
Last Ex-Dividend
Jun 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.01BCNY2.39B · vs all stocks (USD)
Trailing P/E
29.48xvs Medical Instruments & Supplies peers
Revenue (TTM)
3.35BCNY499.51M · vs all stocks (USD)
Profit Margin
15.25%vs Medical Instruments & Supplies peers
Beta
0.2710xvs all stocks
52-Week Change
-5.61%vs all stocks
Market Capitalization
16.01BCNY2.39B · vs all stocks (USD)
Enterprise Value
13.46BCNY2.01B · vs all stocks (USD)
Trailing P/E
29.48xvs Medical Instruments & Supplies peers
Forward P/E
21.34xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.53xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.60xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.02xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
18.05xvs Medical Instruments & Supplies peers
Gross Margin
65.68%vs Medical Instruments & Supplies peers
Profit Margin
15.25%vs Medical Instruments & Supplies peers
Operating Margin
23.93%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
7.79%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
11.89%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.35BCNY499.51M · vs all stocks (USD)
Revenue per Share (TTM)
17.95CNYUpdated Sep 22, 2026Quarterly Revenue Growth
0.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
2.11BCNY314.87M · vs all stocks (USD)
EBITDA (TTM)
755.88MCNY112.83M · vs all stocks (USD)
Net Income (TTM)
510.37MCNY76.18M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
635.73MCNY94.89M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
357.92MCNY53.43M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.17%vs all stocks
5-Year Average Dividend Yield
1.25%vs all stocks
Payout Ratio
54.74%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
211.73MCNYFY2025 · Dec 31, 2025Revenue
3.18BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.14BCNYFY2025 · Dec 31, 2025Gross Profit
2.04BCNYFY2025 · Dec 31, 2025Operating Income
661.63MCNY98.76M · vs all stocks (USD)
Pre-tax Income
691.15MCNYFY2025 · Dec 31, 2025Income Tax Expense
108.60MCNYFY2025 · Dec 31, 2025Net Income
582.56MCNYFY2025 · Dec 31, 2025EBIT
695.69MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
872.75MCNYFY2025 · Dec 31, 2025Research & Development
199.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
472.72MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.18MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
69.36MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.54MCNYFY2025 · Dec 31, 2025EPS (Basic)
3.05CNYFY2025 · Dec 31, 2025EPS (Diluted)
3.05CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
186.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
186.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
582.56MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-12.23MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
537.95MCNYFY2025 · Dec 31, 2025Free Cash Flow
286.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.44BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
582.56MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.28MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
16.35MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-62.24MCNYFY2025 · Dec 31, 2025Capital Expenditures
-251.23MCNYFY2025 · Dec 31, 2025Net Acquisitions
-240.28MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.06BCNYFY2025 · Dec 31, 2025Sale of Investments
1.56BCNYFY2025 · Dec 31, 2025Other Investing Activity
60.59MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-925.01MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
190.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-73.52MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-282.30MCNYFY2025 · Dec 31, 2025Other Financing Charges
-38.01MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-203.83MCNYFY2025 · Dec 31, 2025Shares Outstanding
187.85MSharesUpdated Sep 22, 2026Float Shares
97.67MSharesUpdated Sep 22, 2026% Held by Insiders
47.55%vs all stocks
% Held by Institutions
16.30%vs all stocks
Total Cash (MRQ)
2.07BCNY309.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
11.11CNYUpdated Sep 22, 2026Total Debt (MRQ)
244.26MCNY36.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0555xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.57xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
22.44CNYUpdated Sep 22, 2026Total Assets
5.46BCNY815.58M · vs all stocks (USD)
Total Current Assets
3.64BCNYFY2025 · Dec 31, 2025Total Liabilities
1.12BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.82BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
117.74MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.00BCNYFY2025 · Dec 31, 2025Cash
1.44BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.69MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.44BCNYFY2025 · Dec 31, 2025Other Short-term Investments
189.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
536.59MCNYFY2025 · Dec 31, 2025Inventory
621.10MCNYFY2025 · Dec 31, 2025Accounts Payable
413.59MCNYFY2025 · Dec 31, 2025Short-term Debt
207.43MCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.53MCNYFY2025 · Dec 31, 2025Long-term Debt
33.81MCNYFY2025 · Dec 31, 2025Common Stock (Book)
187.85MCNYFY2025 · Dec 31, 2025Retained Earnings
1.95BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.34BCNY648.16M · vs all stocks (USD)
Treasury Stock
90.03MCNYFY2025 · Dec 31, 202552-Week Low
65.70CNYUpdated Sep 22, 202652-Week High
100.99CNYUpdated Sep 22, 202652-Week Change
-5.61%vs all stocks
Beta
0.2710xvs all stocks
50-Day MA
75.14CNYUpdated Sep 22, 2026200-Day MA
77.56CNYUpdated Sep 22, 2026Avg 10-Day Volume
2.70MSharesUpdated Sep 22, 2026Avg 30-Day Volume
2.56MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
2.74CNYUpdated Sep 22, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.65: safe zoneNotable
Altman Z-Score: 10.65
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.39B, above the global median of $1.18BNotable
Market cap (USD): 2,389,847,894.433Global Median: 1,180,223,658.953
Levered free cash flow is $53.43M, above the global median of $18.73MNotable
Levered free cash flow (USD): 53,427,009.775Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Yongtai Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Aker Solutions ASA
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suzhou Tztek Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Eutelsat Communications S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Yonghe Refrigerant Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou UIGreen Micro&Nano Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui XDLK Microsystems Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kennametal Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Injet Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Anfu Battery Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
NVIDIA Corporation
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
APT Medical Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Castrol India Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated